The Nigerian Federal Government is intensifying efforts to prevent and detect liver cancer early by strengthening the prevention and control of hepatitis B and C. This initiative was announced by the Minister of State for Health, Dr Adekunle Salako.
Nigeria’s Federal Government has unveiled seven new herbal medicines developed by the National Institute for Pharmaceutical Research and Development (NNMDA) for treating cancers, hepatitis B, and other conditions, aiming to boost local healthcare solutions.
Europe is unlikely to eliminate viral hepatitis by 2030 due to failures in child vaccination and insufficient prevention measures, according to the ECDC, with millions of Europeans living with chronic infection.
A Hong Kong woman, whose mother and grandmother died of liver cancer, was saved by early screening after discovering she carried a hepatitis B infection, preventing a similar late-stage diagnosis.
Ahead of World Hepatitis Day, doctors from Austrumu slimnīca remind the public that liver health is threatened by both alcohol and viral hepatitis. They emphasize that blood tests can provide peace of mind regarding Hepatitis B or C.
On World Hepatitis Day, the Portuguese Society of Gastroenterology called on citizens to undergo screening for hepatitis B and C, highlighting the ongoing efforts towards eradicating viral hepatitis.
Dr. Nonye Soludo, the wife of the Governor of Anambra State, has urged for increased investment and collective action to eliminate mother-to-child transmission of HIV, hepatitis B, and syphilis in the state, emphasizing that this goal is achievable.
Patients in Greece will now be able to obtain high-cost medications for Hepatitis B and asthma from private pharmacies across the country, according to the president of pharmacists.
An experimental drug for Hepatitis B, the first of its kind, may allow some patients to discontinue therapy without signs of the dangerous virus in the liver, offering a 'functional cure'.
Five new cases of HIV were reported in April, with an additional seven cases of other sexually and blood-borne infections, including syphilis, viral hepatitis B, and viral hepatitis C.
The World Health Organization (WHO) has identified Nigeria as one of the countries contributing significantly to global hepatitis deaths, according to a 2024 report on viral hepatitis B and C.
A recent WHO report has identified Nigeria as one of the countries with the highest number of hepatitis deaths in 2024, contributing to 1.34 million global deaths from hepatitis B and C.
The Institute of Public Health in North Macedonia reported that chickenpox was the most common infectious disease in March. The report also noted new cases of HIV, syphilis, viral hepatitis B, chlamydia, and viral hepatitis C.
Former patients of a dental clinic in Brantford, Ontario, have been advised by public health officials to undergo testing for hepatitis B, hepatitis C, and HIV following an investigation into an infection prevention and control lapse.
A Hepatitis B vaccine study led by Danish researchers and funded by the US, involving infants in Guinea-Bissau, has drawn sharp criticism from the World Health Organization.
A Rolling Stone investigation uncovered irregularities in the ethics review of a $1.6 million research grant to examine the effects of a birth dose of the hepatitis B vaccine in Guinea-Bissau
The Niger State government has disclosed a high prevalence of Hepatitis B, affecting 7.5% of 20,000 individuals tested, and is implementing free testing and treatment programs.
The Benue state government in Nigeria has reported 193 pregnant women tested positive for Hepatitis B in 2025, highlighting the ongoing challenge of viral hepatitis in the region despite efforts to curb its spread.
Doctors discovered a man suffering from hepatitis B and liver failure after he attempted to treat jaundice at home, highlighting the dangers of self-medication for serious conditions.
On the occasion of World Hepatitis Day (July 28), Greece's National Public Health Organization (EODY) emphasized the country's significant steps in prevention, early diagnosis, and treatment access for viral hepatitis B and C.
Kano State in Nigeria is intensifying its campaign to eliminate mother-to-child transmission of HIV, Hepatitis B, and Syphilis, emphasizing the preventability and curability of these infections.
The WHO Regional Director for Africa, Mohamed Janabi, has urged the continent to expand access to hepatitis care, noting that viral hepatitis remains a major public health challenge despite a 25% decline in new hepatitis B infections between 2015 and 2024.
Dr. Nonye Soludo is calling for increased investment and collective action to eliminate mother-to-child HIV transmission, Hepatitis B, and Syphilis in Anambra State, Nigeria.
GSK's experimental chronic hepatitis B drug has shown promising results in key studies, helping one in five patients achieve a functional cure. This development could offer a significant breakthrough for a subset of patients.
The World Health Organization (WHO) announced that global progress in eliminating hepatitis is too slow, despite available tools to combat the disease which claims over a million lives annually. The organization highlighted that viral hepatitis B and C are responsible for 95% of hepatitis-related deaths.
A growing number of liver transplant patients are now being linked to obesity and diabetes, rather than the previously more common cause of hepatitis B.
A study on hepatitis B vaccination conducted in Guinea-Bissau and partially funded by American institutions has sparked controversy after researchers proposed that only half...
NAT tests are more expensive but more accurate in detecting HIV, Hepatitis B, C viruses in the blood; petitioner sought to protect thalassemia patients who require frequent blood transfusions and are at risk from infected blood
Fifteen US states are suing the government after the Health Minister announced a reduction in recommended childhood vaccinations, including those for rotavirus, influenza, and hepatitis B.
The World Health Organization has criticised a planned US-funded vaccine trial in Guinea-Bissau as 'unethical' for giving some newborns an established hepatitis B treatment while withholding it from others.
The US has temporarily suspended routine visa processing in Abuja, while the Nigerian government announced the unveiling of new herbal medicines for various ailments including cancers and hepatitis B.
More than three million Ghanaians are estimated to be living with hepatitis B, with Northern Ghana bearing the highest burden, as the Health Ministry strengthens elimination efforts.
On World Hepatitis Day, the World Health Organization (WHO) reiterated its goal to reduce the number of new chronic hepatitis B and C infections by 90 percent by the year 2030.
An article highlights the critical need for early therapy for Hepatitis B in India, noting that many individuals may not show symptoms until it's too late.
Former President John Dramani Mahama has expressed concern that millions of Africans are living with undiagnosed hepatitis B and C, highlighting persistent health challenges across the continent.
Over 800 former patients of Dr. George Chan Dentistry in Brantford, Ontario, have been reminded by Grand Erie Public Health to get tested for hepatitis B, hepatitis C, and HIV following the dentist's resignation.
Seychelles and Eritrea have adopted a new WHO-prequalified test aimed at eliminating mother-to-child transmission of HIV, syphilis, and hepatitis B, enhancing their public health efforts.
A new drug for pancreatic cancer has shown significant potential, with scientists reporting it could nearly double the survival rate for patients. This breakthrough was met with a standing ovation at an oncology conference, marking a potential turning point in treatment.
Scientists have identified a potential cure for chronic Hepatitis B, with a new drug showing promise in curing one in five patients who do not naturally recover from the infection.
While genome editing carries risks, a new technology called epigenome editing shows promise in tackling diseases such as atherosclerosis and hepatitis B. This approach could offer new therapeutic avenues.
Kenya is reportedly struggling with the prevalence of sexually transmitted infections like HIV, HPV, chlamydia, syphilis, and hepatitis B, highlighting issues in testing and prevention efforts.
Dr. Emmanuel Egbroko, CEO of Inocul8, has dismissed claims that the hepatitis B vaccine causes infection, labeling them as misinformation. He urged wider immunization to combat the disease.
A growing number of liver transplant patients are now being linked to obesity and diabetes, indicating a shift in primary causes compared to traditional factors like hepatitis B.
Hepatitis D (HDV) is often a silent and undiagnosed co-infection with Hepatitis B, leading to a more severe form of viral hepatitis and significant liver damage.